Laboratory Reference Grade CompoundsInsulation Foam Protected • Dispatched Nationwide
Dispatched from Metro Manila · J&T Express•Instant GCash, Maya & Bank QR
RTT60
RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓₱6,300.00
Low Stock (6)
InclusionVial Only
Net Content60MG
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (60MG)
Diluent:mL
Concentration60.00 mg/mLin 1.0mL BAC
Standard Dose1.0 mg – 2.0 mg weekly starting research exposureSyringe: 5.0 units (0.05 mL)
Scale (1 Unit)600 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
RTT6060MG · Vial Only
₱6,300.00
1
Technical Specification & Protocol Dossier
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
P
Research MonographPharmacological Profile & Mechanism of Action
What it is: RTT60 is an advanced fixed 60 mg research blend containing 20 mg retatrutide and 40 mg tirzepatide in a standardized 1:2 co-lyophilized formulation.
How it works: Retatrutide simultaneously activates GLP-1, GIP, and Glucagon receptors, promoting hepatic energy expenditure, lipid oxidation, and thermogenesis. Combined with Tirzepatide’s proven dual incretin insulinotropic and appetite-regulation pathways, RTT60 offers researchers a unified model for investigating multi-receptor metabolic cascades.
Compound & Molecular Specifications
Certificate of Analysis StandardsTarget CategoryMulti-Peptide Blends
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number2381089-83-2 / 2023788-19-2
Purity Specification≥99.0% (Dual HPLC Certified)
Net Content Options60MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
